Pulse nav.journalClub Débats actifs Tendances Explorer Chercheurs

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Accueil Explorer nav.journalClub Tendances

⌘+K

Randomized Double-blind Trial of Treatment of Vitiligo | Synapse

May 1, 2007

Randomized Double-blind Trial of Treatment of Vitiligo

Key Points

Key points are not available for this paper at this time.

Abstract

In the treatment of nonsegmental vitiligo, NB-UVB therapy is superior to oral PUVA therapy.

Demander à l'IA

Like

Bookmark

Share

Demander à l'IA

Like

Bookmark

Share

Cite This Study

Yones et al. (Tue,) studied this question.

synapsesocial.com/papers/69d8cc0817a1cc0598d187f5 https://doi.org/https://doi.org/10.1001/archderm.143.5.578

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Interventions for vitiligo: a Cochrane systematic review2006 · 28 citations
2Treatment of Vitiligo With UV-B Radiation vs Topical Psoralen Plus UV-A1997 · 350 citations
3British Photodermatology Group guidelines for PUVA1995 · 116 citations
4Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment2004 · 100 citations
5Psoralen–ultraviolet A <i>vs</i>. narrow‐band ultraviolet B phototherapy for the treatment of vitiligo2006 · 98 citations